Identification of Biomarkers in Neuropsychiatric Disorders Based on Systems Biology and Epigenetics
Clinically useful biomarkers are available for some neuropsychiatric disorders like fragile X syndrome, Rett syndrome, and Huntington’s disease. Despite many decades of research on the pathogenesis of neuropsychiatric disorders like schizophrenia (SZ), bipolar disorder (BD), and major depressive dis...
Main Author: | Jacob Peedicayil |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2019.00985/full |
Similar Items
-
Editorial: The role of epigenetics in neuropsychiatric disorders
by: Margret Shirinian, et al.
Published: (2022-07-01) -
Epigenetic Regulations in Neuropsychiatric Disorders
by: Janise N. Kuehner, et al.
Published: (2019-04-01) -
Profiling classical neuropsychiatric biomarkers across biological fluids and following continuous lumbar puncture: A guide to sample type and time
by: Gallen Triana-Baltzer, et al.
Published: (2022-05-01) -
Circulating microRNAs as a Novel Class of Potential Diagnostic Biomarkers in Neuropsychiatric Disorders
by: Kichukova Tatyana M., et al.
Published: (2015-12-01) -
Exosomes as Emerging Biomarker Tools in Neurodegenerative and Neuropsychiatric Disorders—A Proteomics Perspective
by: Boby Mathew, et al.
Published: (2021-02-01)